Cerebrospinal fluid from Alzheimer's disease patients contains fungal proteins and DNA

Journal of Alzheimer's Disease

Volumn 47, Issue 4, 2015, Pages 873-876

  Alonso, Ruth ^a   Pisa, Diana ^a   Rábano, Alberto ^b   Rodal, Izaskun ^b   Carrasco, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Cerebrospinal fluid biomarker; Fungal DNA; Fungal infection; Neurodegenerative disease; Protein biomarker

Indexed keywords

BETA TUBULIN; BIOLOGICAL MARKER; ENOLASE; FUNGAL DNA; FUNGAL PROTEIN; FUNGUS ANTIBODY; FUNGUS ANTIGEN;

ADULT; AGED; ALZHEIMER DISEASE; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; HUMAN; MALE; MIDDLE AGED; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SLOT BLOT HYBRIDIZATION; VERY ELDERLY; MICROBIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DNA, FUNGAL; FEMALE; FUNGAL PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 84939432696     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150382     Document Type: Review

References (34)

1. De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT (2012) Infectious agents and neurodegeneration. Mol Neurobiol 46, 614-638.
2. Honjo K, van Reekum R, Verhoeff NP (2009) Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 5, 348-360.
3. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25, 619-627.
4. Maheshwari P, Eslick GD (2015) Bacterial infection and Alzheimer's disease: A meta-analysis. J Alzheimers Dis 43, 957-966.
5. Agostini S, Clerici M, Mancuso R (2014) How plausible is a link between HSV-1 infection and Alzheimer's disease? Expert Rev Anti Infect Ther 12, 275-278.
6. Itzhaki RF, Cosby SL, Wozniak MA (2008) Herpes simplex virus type 1 and Alzheimer's disease: The autophagy connection. J Neurovirol 14, 1-4.
7. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349, 241-244.
8. Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217, 131-138.
9. WozniakMA,Shipley SJ, CombrinckM,Wilcock GK, Itzhaki RF (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 75, 300-306.
10. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187, 23-42.
11. Nochlin D, Shaw CM, Campbell LA, Kuo CC (1999) Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurolog 53, 1888.
12. Ring RH, Lyons JM (2000) Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J Clin Microbiol 38, 2591-2594.
13. Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslen M (2013) Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol 260, 620-626.
14. Paradowski B, JaremkoM, DoboszT, Leszek J, NogaL(2007) Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia. J Neurol 254, 154-159.
15. Alonso R, Pisa D, Rabano A, Carrasco L (2014) Alzheimer's disease and disseminated mycoses. Eur J Clin Microbiol Infect Dis 33, 1125-1132.
16. Alonso R, Pisa D, Marina AI, Morato E, Rabano A, CarrascoL (2014) Fungal infection in patients with Alzheimer's disease. J Alzheimers Dis 41, 301-311.
17. Pisa D, Alonso R, Juarranz A, Rabano A, Carrasco L (2015) Direct visualization of fungal infection in brains from patients with Alzheimer's disease. J Alzheimers Dis 43, 613-624.
18. Alonso R, Pisa D, Marina AI, Morato E, Rabano A, Rodal I, Carrasco L (2015) Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Int J Biol Sci 11, 546-558.
19. Pisa D, Alonso R, Jimenez-Jimenez FJ, Carrasco L (2013) Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Eur J Clin Microbiol Infect Dis 32, 795-801.
20. Pisa D, Ramos M, Garcia P, Escoto R, Barraquer R, Molina S, Carrasco L (2008) Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy. J Clin Microbiol 46, 130-135.
21. Blennow K, Hampel H,Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144.
22. Lista S, Zetterberg H, Dubois B, Blennow K, Hampel H (2014) Cerebrospinal fluid analysis in Alzheimer's disease: Technical issues and future developments. J Neurol 261, 1234-1243.
23. Rosen C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer's disease-current concepts. Mol Neurodegener 8, 20.
24. Sui X, Liu J, Yang X (2014) Cerebrospinal fluid biomarkers of Alzheimer's disease. Neurosci Bull 30, 233-242.
25. Zafari S, Backes C, Meese E, Keller A (2015) Circulating biomarker panels in Alzheimer's disease. Gerontology. doi: 10. 1159-000375236
26. Hampel H, BlennowK, ShawLM, Hoessler YC, ZetterbergH, Trojanowski JQ (2010) Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Exp Gerontol 45, 30-40.
27. Mo JA, Lim JH, Sul AR, Lee M, Youn YC, Kim HJ (2015) Cerebrospinal fluid beta-Amyloid1-42 levels in the differential diagnosis of Alzheimer's disease-systematic review and meta-analysis. PLoS One 10, e0116802.
28. Zetterberg H, Blennow K, Hanse E (2010) Amyloid beta and APP as biomarkers for Alzheimer's disease. Exp Gerontol 45, 23-29.
29. Gisslen M, Krut J, Andreasson U, BlennowK, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, PriceRW, Zetterberg H (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9, 63.
30. Choi J, LeeHW, SukK(2011) Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease. J Neurol 258, 2181-2185.
31. Hinsinger G, Galeotti N, Nabholz N, Urbach S, Rigau V, Demattei C, Lehmann S, Camu W, Labauge P, Castelnovo G, Brassat D, Loussouarn D, Salou M, Laplaud D, Casez O, Bockaert J, Marin P, Thouvenot E (2015) Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Mult Scler. doi: 10. 1177-1352458514561906
32. Modvig S, Degn M, Roed H, Sorensen T, Larsson H, Langkilde A, Frederiksen J, Sellebjerg F (2015) Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis. Mult Scler. doi: 10. 1177-1352458515574148
33. Pagliardini V, Pagliardini S, Corrado L, Lucenti A, Panigati L, Bersano E, Servo S, Cantello R, D'Alfonso S, Mazzini L (2015) Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: A survey clinic-based study. J Neurol Sci 348, 245-250.
34. Watabe-Rudolph M, Song Z, Lausser L, Schnack C, Begus-Nahrmann Y, Scheithauer MO, Rettinger G, Otto M, Tumani H, Thal DR, Attems J, Jellinger KA, Kestler HA, von Arnim CA, Rudolph KL (2012) Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology 78, 569-577.